Comparing the Safety and Cosmetic Outcomes Between Laparoscopic Versus Traditional Open Breast-conserving Surgery
A Multicenter, Open and Prospective Randomized Controlled Trial Comparing the Safety and Cosmetic Outcomes of Laparoscopic Breast-conserving Surgery Versus Traditional Open Breast-conserving Surgery.
1 other identifier
interventional
184
1 country
1
Brief Summary
In recent years, laparoscopic breast cancer surgery has received wide attention. It has advantages of minimal invasiveness, clear anatomical exposure, and good aesthetic effects. Based on these advantages, we propose whether laparoscopy is suitable for breast-conserving surgery for breast cancer. The standard procedure of laparoscopic breast-conserving surgery is unclear. More high-quality clinical studies are required. Therefore, we intend to conduct a multi-center, open, productive, randomized controlled study comparing the safety and cosmetic effects of endoscopic breast-conserving with traditional open breast-conserving surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable breast-cancer
Started Oct 2024
Typical duration for not_applicable breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 23, 2024
CompletedStudy Start
First participant enrolled
October 25, 2024
CompletedFirst Posted
Study publicly available on registry
November 4, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 25, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 25, 2027
November 4, 2024
November 1, 2024
2.6 years
October 23, 2024
November 1, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
breast appearance satisfaction
Whether laparoscopic breast-conserving and traditional open breast-conserving had significant differences postoperative cosmetic outcomes. One of the evaluation indicators is breast appearance satisfaction. Our study chooses BREAST-Q questionnaire to evaluate patients' breast appearance satisfaction.
2 years
breast aesthetic scores
Whether laparoscopic breast-conserving and traditional open breast-conserving had significant differences postoperative cosmetic outcomes. Another of the evaluation indicators is breast aesthetic scores. We will invite two Plastic surgeons who did not participate in the study to judge patients' photographs, which is taken 18 months after the surgery, according to the Harris evaluation criteria.
2 years
Secondary Outcomes (3)
Complications
1 year
Quality of Life
1 year
local recurrence rate
2 years
Study Arms (2)
Laparoscopic breast-conserving surgery
EXPERIMENTALSubjects who is going to accept laparoscopic breast-conserving surgery.
Traditional open breast-conserving surgery
ACTIVE COMPARATORSubjects who is going to accept traditional open breast-conserving surgery.
Interventions
Use laparoscopic surgery to treat breast cancer patients who want and have the opportunity to preserve their breast
Treat breast cancer patients who want and have the opportunity to preserve their breast with traditional open breast-conserving surgery.
Eligibility Criteria
You may qualify if:
- Female over the age of 18
- Preoperative pathologically confirmed invasive breast cancer or ductal carcinoma in situ
- Clinical classification T1, T2 (maximum tumor diameter ≤5cm)
- Single-center tumor (preoperative confirmation by B-ultrasound, MRI and other imaging examinations)
- No clinical or imaging evidence of distant metastasis
- Able and willing to sign informed consent
You may not qualify if:
- Tumor in the lower inner quadrant
- Tumor in multiple quadrants
- Imaging or intraoperative pathology indicates tumor invasion of the nipple areola, skin, or pectoralis major
- Locally advanced breast cancer patients are undergoing neoadjuvant therapy
- Tumor in multiple quadrants
- Have been participating in other clinical trials, which may affect the participation in this trial
- Previous history of breast cancer (patients with recurrence after ipilateral breast-conserving surgery)
- Pregnant and lactating women
- Patients with severe cardiopulmonary disease or severely impaired lung function are not suitable for surgical establishment of an air cavity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Xiaochen Wang
Hangzhou, Zhejiang, 31000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Xiaochen - Wang, Doctorate
Second Affiliated Hospital, School of Medicine, Zhejiang University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 23, 2024
First Posted
November 4, 2024
Study Start
October 25, 2024
Primary Completion (Estimated)
May 25, 2027
Study Completion (Estimated)
October 25, 2027
Last Updated
November 4, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share